A detailed history of Hudson Bay Capital Management LP transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 65,000 shares of SRPT stock, worth $7.73 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
65,000
Previous 7,500 766.67%
Holding current value
$7.73 Million
Previous $1.19 Million 585.06%
% of portfolio
0.04%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$124.33 - $156.75 $7.15 Million - $9.01 Million
57,500 Added 766.67%
65,000 $8.12 Million
Q2 2024

Aug 14, 2024

BUY
$113.33 - $163.85 $849,975 - $1.23 Million
7,500 New
7,500 $1.19 Million
Q4 2023

Feb 14, 2024

BUY
$67.31 - $124.76 $2.91 Million - $5.39 Million
43,208 Added 96.02%
88,208 $8.51 Million
Q3 2023

Nov 14, 2023

BUY
$102.5 - $123.59 $4.61 Million - $5.56 Million
45,000 New
45,000 $5.45 Million
Q4 2022

Feb 14, 2023

SELL
$100.86 - $132.13 $12.4 Million - $16.2 Million
-122,620 Reduced 72.13%
47,380 $6.14 Million
Q3 2022

Nov 14, 2022

SELL
$75.71 - $119.24 $1.32 Million - $2.09 Million
-17,500 Reduced 9.33%
170,000 $18.8 Million
Q2 2022

Aug 12, 2022

BUY
$62.69 - $88.44 $9.09 Million - $12.8 Million
145,000 Added 341.18%
187,500 $14.1 Million
Q1 2022

May 16, 2022

BUY
$63.15 - $90.42 $2.68 Million - $3.84 Million
42,500 New
42,500 $3.32 Million
Q3 2021

Nov 15, 2021

SELL
$65.97 - $92.48 $2.47 Million - $3.47 Million
-37,500 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$69.38 - $86.75 $659,110 - $824,125
9,500 Added 33.93%
37,500 $2.92 Million
Q1 2021

May 14, 2021

BUY
$72.25 - $168.95 $2.02 Million - $4.73 Million
28,000 New
28,000 $2.09 Million
Q4 2019

Feb 12, 2020

SELL
$76.53 - $135.58 $3.44 Million - $6.1 Million
-45,000 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$72.81 - $156.91 $3.28 Million - $7.06 Million
45,000 New
45,000 $3.39 Million
Q1 2019

May 15, 2019

SELL
$106.67 - $151.68 $1.07 Million - $1.52 Million
-10,000 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$115.31 - $161.51 $1.15 Million - $1.62 Million
-10,000 Reduced 50.0%
10,000 $1.62 Million
Q2 2018

Aug 13, 2018

BUY
$71.74 - $153.69 $1.43 Million - $3.07 Million
20,000 New
20,000 $2.64 Million
Q1 2018

May 14, 2018

SELL
$54.02 - $82.27 $9.21 Million - $14 Million
-170,400 Closed
0 $0
Q4 2017

Feb 12, 2018

SELL
$47.64 - $56.75 $925,025 - $1.1 Million
-19,417 Reduced 10.23%
170,400 $9.48 Million
Q3 2017

Nov 13, 2017

BUY
$35.73 - $47.15 $6.78 Million - $8.95 Million
189,817
189,817 $8.61 Million

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $10.4B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.